Hematogenix Unites With 19 Organizations from the Healthcare Community to Form COVID-19 Testing Industry Consortium

Hematogenix Unites With 19 Organizations from the Healthcare Community to Form COVID-19 Testing Industry Consortium

Hematogenix Announces the Availability of COVID-19 Antibody Testing

Hematogenix Announces the Availability of COVID-19 Antibody Testing

Hematogenix Adds Myeloid Genotyping to its Menu of Genomic Testing

Hematogenix Adds Myeloid Genotyping to its Menu of Genomic Testing

China Expansion Press Release

Hematogenix Announces the Opening of Their Newest Facility in Shanghai, China

 PD-L1 Press Release

Hematogenix Laboratory Services, LLC Introduces the Availability of PD-L1 Companion Diagnostic Tests

THxID®-BRAF Press Release

Hematogenix Laboratory Services to Offer FDA Approved THxID®‐BRAF Companion Diagnostic Testing Services in the US

RNAscope®-ISH Press Release 

Hematogenix Laboratory Services – The First Diagnostic Testing and CLIA-Certified Biomarker Services Laboratory to Offer Advanced Cell Diagnostics, RNAscope® Assays to Clients

New Test Offering - MRD-CLL

Hematogenix Laboratory Services Launches Minimal Residual Disease (MRD) Evaluation for Chronic Lymphocytic Leukemia (CLL) Using the Standardized ERIC Method

Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer

Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer